
As non-invasive as possible, as invasive as necessary. The Dräger Savina 300 NIV with automatic leak compensation in all ventilation modes supports the seamless transition from high-flow oxygen therapy to non-invasive ventilation and invasive ventilation. The built-in-turbine with rapid response time and external batteries allows operation independently from the central gas supply.
Patient-ventilator asynchrony is a common but often unrecognized and undertreated problem in non-invasive ventilation (NIV) that may occur in up to 25 % of ventilated patients1. It is mostly related to missed triggers and delayed cycling associated w … More information
ith leaks2.A relevant indicator of a ventilator’s efficiency is the inspiratory delay, which is the time needed for the ventilator to reach positive pressure in the patient’s airway from the start of inspiratory effort. A long inspiratory delay significantly increases the patient’s work of breathing3. Savina 300 NIV very quick response to triggering and its pressurization capacity reduces the patients work of breathing and discomfort resulting in a remarkably low asynchrony index4.Leakage occurs not only during inspiration but also during expiration. If expiratory leakage cannot be measured accurately, it results in inaccurate compensation of targeted tidal volumes3. Savina 300 devices effectively compensate air leaks and deliver the prescribed tidal volume regardless air leak or inspiratory effort4.Patients in pressure support ventilation utilizing a preselected inspiratory cycling criteria (termination) may experience expiratory asynchrony5. Furthermore, studies show that the cycling setting must be individualized, since factors like e.g., response time of the respiratory system and breathing frequency will probably affect how a patient responds6. In all Savina 300 devices the inspiratory termination can be individually adjusted to the patient’s lung properties and breathing pattern and thus achieve a better adaptation.A comparison of high-flow nasal oxygen delivery vs Venturi mask oxygen therapy has shown improvements in oxygenation, comfort, and clinical outcomes. When using a high-flow nasal O2 system, this study demonstrated a reduced need for non-invasive vent … More information
ilation by approximately 80 %, less episodes of O2 desaturation by an estimated 66 %, less need for reintubation by approximately 80 %, and a reduced length of stay in the ICU by an approximate average of 1.3 days7High-Flow Oxygen Therapy supports recovery after extubation and non-invasive ventilation: flushing of anatomical dead space thereby functionally reducing dead space and improving respiratory efficiency8Time management for the caregiver is streamlined as one device can remain at the bedside of the patient simply by changing the patient-circuit interface: complete set-up for High-Flow nasal O2-therapyEnhanced patient comfort due to the soft nasal prongs which ensures a comfortable fit. Skin lesions and other undesirable effects associated with masks are reduced9. Heating and humidification of the gas mix further improves both patient tolerance and therapeutic efficacy10, 11, 12Operate the Savina 300 NIV ventilator with confidence in any situation, thereby lower education times and help to avoid human errors.
The Savina 300 NIV compresses ambient air for the breathing gas* allowing the device to operate independently from the central gas supply.
